Dr. Kwo is currently Professor of Medicine and Director of Hepatology at the Stanford University where he joined the faculty in November 2016.
Prior to joining the faculty at Stanford, he was at Indiana University for 21 years where he served as the Medical Director of Liver Transplantation. He has distinguished himself in the field of Hepatitis C therapeutics and has been the principal investigator on multiple international trials. He recently authored the ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.

He has been named America’s Best Doctors: Gastroenterology/Hepatology, Best Doctors in America (2003-2015); America’s Top Doctors Gastroenterology/Hepatology, Consumers Research Council of America (2002-2014); and America’s Top Doctors, Gastroenterology/Hepatology, Castle Connelly Publishing, (2002-2016, 2018-2020).

Dr. Kwo performed his Residency at the University of Maryland Medical Center (1991). He earned his Board Certification from the American Board of Internal Medicine, Transplant Hepatology in 2006. He earned Board Certification from the American Board of Internal Medicine, Gastroenterology in 1995.